Welcome to LookChem.com Sign In|Join Free

CAS

  • or

138112-82-0

138112-82-0

Post Buying Request

138112-82-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

138112-82-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 138112-82-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,8,1,1 and 2 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 138112-82:
(8*1)+(7*3)+(6*8)+(5*1)+(4*1)+(3*2)+(2*8)+(1*2)=110
110 % 10 = 0
So 138112-82-0 is a valid CAS Registry Number.
InChI:InChI=1/C17H20ClNO2/c1-21-15-8-7-13-4-2-5-14(16(13)12-15)9-11-19-17(20)6-3-10-18/h2,4-5,7-8,12H,3,6,9-11H2,1H3,(H,19,20)

138112-82-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-chloro-N-[2-(7-methoxynaphthalen-1-yl)ethyl]butanamide

1.2 Other means of identification

Product number -
Other names N-[2-(7-methoxynaphth-1-yl)ethyl]-4chlorobutyramide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:138112-82-0 SDS

138112-82-0Downstream Products

138112-82-0Relevant articles and documents

Novel conformationally constrained analogues of agomelatine as new melatoninergic ligands

Rami, Marouan,Landagaray, Elodie,Ettaoussi, Mohamed,Boukhalfa, Koussayla,Caignard, Daniel-Henri,Delagrange, Philippe,Berthelot, Pascal,Yous, Said

, p. 154 - 166 (2013/03/13)

Novel conformationally restricted analogues of agomelatine were synthesized and pharmacologically evaluated at MT1 and MT2 melatoninergic receptors. Replacement of the N-Acetyl side chain of agomelatine by oxathiadiazole-2-oxide (compound 3), oxadiazole-5(4H)-one (compound 4), tetrazole (compound 5), oxazolidinone (compound 7a), pyrrolidinone (compound 7b), imidazolidinedione (compound 12), thiazole (compounds 13 and 14) and isoxazole moieties (compound 15) led to a decrease of the melatoninergic binding affinities, particularly at MT1. Compounds 7a and 7b exhibiting nanomolar affinity towards the MT2 receptors subtypes have shown the most interesting pharmacological results of this series with the appearance of a weak MT2-selectivity.

Compounds having a naphthalene structure

-

, (2008/06/13)

Compounds of general formula: STR1 in which A and R are defined in the description.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 138112-82-0